1 Food and Agriculture Organization of the United Nations and World Health Organization (2002) Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London/Ontario: FAO/WHO.
3 van Ommen B, Keijer J, Heil SG, et al. (2009) Challenging homeostasis to define biomarkers for nutrition related health. Mol Nutr Food Res 53, 795–804.
4 Albers R, Antoine JM, Bourdet-Sicard R, et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452–481.
5 Gleeson M, Pyne DB, McDonald WA, et al. (1996) Pneumococcal antibody responses in elite swimmers. Clin Exp Immunol 105, 238–244.
6 Cummings JH, Antoine JM, Azpiroz F, et al. (2004) PASSCLAIM – gut health and immunity. Eur J Nutr 43, Suppl. 2, II118–II173.
7 Kekkonen RA, Lummela N, Karjalainen H, et al. (2008) Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14, 2029–2036.
8 Fukushima Y, Kawata Y, Hara H, et al. (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39–44.
9 Schiffrin EJ, Rochat F, Link-Amster H, et al. (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491–497.
10 Villena J, Racedo S, Aguero G, et al. (2005) Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 135, 1462–1469.
11 Gackowska L, Michalkiewicz J, Krotkiewski M, et al. (2006) Combined effect of different lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells. J Physiol Pharmacol 57, Suppl. 9, 13–21.
12 Lomax AR & Calder PC (2009) Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 15, 1428–1518.
13 Boge T, Remigy M, Vaudaine S, et al. (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27, 5677–5684.
14 Olivares M, Diaz-Ropero MP, Sierra S, et al. (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254–260.
15 de Vrese M, Rautenberg P, Laue C, et al. (2005) Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 44, 406–413.
16 French PW & Penny R (2009) Use of probiotic bacteria as an adjuvant for an influenza vaccine. Int J Prebiotics Probiotics 4, 175–180.
17 Hatakka K, Savilahti E, Ponka A, et al. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322, 1327.
18 Guillemard E, Tondu F, Lacoin F, et al. (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103, 58–68.
19 Tubelius P, Stan V & Zachrisson A (2005) Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. Environ Health 4, 25.
20 Leyer GJ, Li S, Mubasher ME, et al. (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124, e172–e179.
21 Hojsak I, Snovak N, Abdovic S, et al. (2010) Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 29, 312–316.
22 Cox AJ, Pyne DB, Saunders PU, et al. (2008) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 44, 222–226.
23 de Vrese M, Winkler P, Rautenberg P, et al. (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24, 6670–6674.
24 Rijkers GT, Bengmark S, Enck P, et al. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 140, 671S–676S.
25 Saresella M, Roda K, Speciale L, et al. (1997) A rapid evaluation of phagocytosis and killing of Candida albicans by CD13+ leukocytes. J Immunol Methods 210, 227–234.
26 Stepanova L, Naykhin A, Kolmskog C, et al. (2002) The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. J Clin Virol 24, 193–201.
27 Kurstak E (1985) Progress in enzyme immunoassays: production of reagents, experimental design, and interpretation. Bull World Health Organ 63, 793–811.
28 Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6, 65–70.
29 Kutzler MA, Kraynyak KA, Nagle SJ, et al. (2010) Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Ther 17, 72–82.
30 Gleeson M (2000) Mucosal immune responses and risk of respiratory illness in elite athletes. Exerc Immunol Rev 6, 5–42.
31 Neville V, Gleeson M & Folland JP (2008) Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc 40, 1228–1236.
32 Berggren A, Lazou Ahren I, Larsson N, et al. (2010) Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 50, 203–210.
33 Merenstein D, Murphy M, Fokar A, et al. (2010) Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 64, 669–677.
34 Merenstein DJ, Smith KH, Scriven M, et al. (2010) The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial. Eur J Clin Nutr 64, 685–691.
35 Rautava S, Arvilommi H & Isolauri E (2006) Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 60, 221–224.
36 Calder PC (2007) Immunological parameters: what do they mean? J Nutr 137, 773S–780S.
37 Burleson GR & Burleson FG (2007) Influenza virus host resistance model. Methods 41, 31–37.
38 Kalia V, Sarkar S, Gourley TS, et al. (2006) Differentiation of memory B and T cells. Curr Opin Immunol 18, 255–264.
39 Cox RJ, Brokstad KA & Ogra P (2004) Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59, 1–15.
40 Thomas CM & Versalovic J (2010) Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1, 148–163.